查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球診斷心電圖 (ECG) 市場：按產品/服務、引線類型、最終用戶、地區分類 - 到2028年的預測
市場調查報告書
商品編碼
1342757

全球診斷心電圖 (ECG) 市場：按產品/服務、引線類型、最終用戶、地區分類 - 到2028年的預測

Diagnostic Electrocardiograph (ECG) Market by Product (Resting ECG, Stress, Mobile Cardiac Telemetry Device, Implantable Loop Recorder) and Service, Lead Type (12-lead, 6-lead, 5- lead), End User, and Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 176 Pages | 訂單完成後即時交付

價格
簡介目錄

全球診斷心電圖機 (ECG) 市場規模預計將從2023年的 81 億美元增至2028年的 113 億美元，預測期內年複合成長率為 6.9%。

這是由於心血管和生活方式相關疾病的盛行率不斷上升，對心臟病早期診斷的需求不斷增加，穿戴式心電圖設備的技術進步，人口高齡化比例不斷增加，醫療保健基礎設施不斷增加，診斷心電圖製造商的需求不斷增加。

按產品類型分類，診斷心電圖市場分為設備和軟體服務。設備部分分為靜止心電圖設備、負載心電圖設備、動態心電圖監測儀、事件監測儀、植入式動態心電圖監測儀、行動心臟遙測設備和智慧心電圖設備。2022年，靜態心電圖設備領域在診斷心電圖市場中佔最大佔有率。這是要素經濟高效的靜態心電圖設備的可用性不斷增加以及靜態心電圖設備在醫院環境中的廣泛採用。

依導程類型，診斷心電圖 (ECG) 市場分為貼片式 12 導程、5 導程、3 導程、6 導程、單導程和其他導程類型（13 導程、18 導程等）。2022年，12導程型在診斷心電圖市場中佔據最大佔有率。 12 導程心電圖設備可提供高度詳細的預測，並有助於解釋心電活動。

按最終用戶分類，診斷心電圖 (ECG) 市場分為醫院、診所、心臟中心、門診手術中心和其他最終用戶。由於心血管疾病盛行率不斷上升、心臟中心的建立以及醫院提供的服務的擴大和改善，醫院、診所和飯店中心細分市場在2022年佔據全球市場的最大佔有率。

本報告考察了全球診斷心電圖 (ECG) 市場，並按產品/服務、引線類型、最終用戶、地區和進入市場的公司概況總結了趨勢。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 價格分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 波特五力分析
  • 贖回場景
  • 法規分析
  • 貿易分析
  • 技術分析
  • 2023-2024年重大會議和活動
  • 影響客戶業務的趨勢/干擾
  • 主要相關人員和採購標準

第6章 診斷心電圖市場（依產品）

  • 介紹
  • 裝置
  • 軟體和服務

第7章 診斷心電圖市場（依導程類型）

  • 介紹
  • 12 導程
  • 5 導程
  • 3 導程
  • 6 導程
  • 單導程
  • 其他

第8章 診斷心電圖市場（依最終用戶）

  • 介紹
  • 醫院、診所、心臟中心
  • 門診手術中心
  • 其他

第9章 診斷心電圖市場，依地區

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東、非洲

第10章 競爭形勢

  • 概述
  • 主要參與企業所採取的策略
  • 收入佔有率分析
  • 市佔率分析
  • 主要企業企業評價矩陣
  • 新創公司/中小企業的企業評估矩陣
  • 競爭標竿管理
  • 競爭情境（2020-2023）

第11章 公司簡介

  • 主要參與企業
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • HILL-ROM HOLDINGS, INC.（BAXTER INTERNATIONAL INC.）
    • FUKUDA DENSHI
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • NIHON KOHDEN CORPORATION
    • OSI SYSTEMS, INC.
    • BPL MEDICAL TECHNOLOGIES
    • SCHILLER AG
    • BITTIUM
    • ACS DIAGNOSTICS
    • ALLENGERS MEDICAL SYSTEMS LTD.
    • BIONET
    • CARDIAC INSIGHT, INC.
    • BTL
  • 其他公司
    • MEDITECH EQUIPMENT CO. LTD.
    • MIDMARK CORPORATION
    • ALIVECOR, INC.
    • VITALCONNECT
    • IRHYTHM TECHNOLOGIES, INC.
    • BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
    • NASIFF ASSOCIATES, INC.
    • VECTRACOR
    • BIOMEDICAL INSTRUMENTS CO. LTD.
    • LIFESIGNALS, INC.

第12章 附錄

簡介目錄
Product Code: MD 2551

The global diagnostic electrocardiogram (ECG) market is projected to reach USD 11.3 billion by 2028 from USD 8.1 billion in 2023, at a CAGR of 6.9% during the forecast period. The rising prevalence of cardiovascular and lifestyle diseases, growing demand for early cardiac diseases diagnosis , technological advancements in wearable ECG devices, increasing proportion of aging population, increasing healthcare infrastructure and growing geographical presence of diagnostic ECG manufacturers globally.

"Resting ECG Devices segment to dominate diagnostic electrocardiogram (ECG) market during the forecast period."

Based on product type, the diagnostic ECG market is segmented into devices and software & Services . The devices segment is categorized into resting ECG devices, stress ECG devices, Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry devices, and smart ECG devices. The resting ECG devices segment captured the largest share of diagnostic ECG market in 2022 attributed to the increasing availability of cost effective resting ECG devices and wider adoption of resting ECG devices in hospital settings.

"12 lead , by lead type , accounted for the largest market share of global diagnostic electrocardiogram (ECG) market in 2022."

Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG market. This is mainly attributed to higher clarity obtained by using a larger number of leads; 12-lead ECG devices provide a highly detailed outlook, making it easier to interpret cardiac electrical activity.

"The hospitals, clinics, and cardiac centers to dominate the global electrocardiogram ECG market in 2022."

Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the increasing prevalence of cardiovascular diseases, establishment of cardiac centers, and increasing government funding to expand and improve the services offered by hospitals.

"The APAC market, by region, to register highest growth rate in the forecast period."

On the basis of region, the diagnostic electrocardiogram (ECG) market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest share and expects to dominate the diagnostic ECG market. The Asia-Pacific market is likely witnessing significant growth owing to increase in disposable income and increase in cardiovascular patient pool. Rising penetration of advanced diagnostic ECG in hospitals, and growing healthcare expenditure

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, MEA- 3%

The prominent players in the diagnostic electrocardiogram (ECG) market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium Corporation (Finland), Fukuda Denshi Co., Ltd. (Japan), BPL Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage

This report studies the diagnostic electrocardiogram (ECG) market based on product type, lead type, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers ( rising prevalence of cardiovascular diseases, increasing geriatric population growing demand for remote monitoring, technological advancements in wireless ECG devices ) restraints (stringent regulatory approvals delaying the approval of diagnosis ECG devices ), opportunities (rising healthcare expenditure across developing countries, high growth offered by emerging markets), and challenges (lack of skilled professional) influencing the growth of diagnostic electrocardiogram (ECG) market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic electrocardiogram (ECG) market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic electrocardiogram (ECG) market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic electrocardiogram (ECG) market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 MARKETS COVERED
    • 1.3.1 GEOGRAPHIC SCOPE
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 KEY MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT ON DIAGNOSTIC ECG MARKET

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 DIAGNOSTIC ECG MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 END USER-BASED MARKET ESTIMATION
    • FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC ECG MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1 RESEARCH ASSUMPTIONS
    • 2.4.2 RESEARCH LIMITATIONS
  • 2.5 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 8 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIAGNOSTIC ECG MARKET OVERVIEW
    • FIGURE 12 INCREASING PREVALENCE OF CVD GLOBALLY TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY PRODUCT & COUNTRY (2022)
    • FIGURE 13 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2022
  • 4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY TYPE, 2023 VS. 2028
    • FIGURE 14 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2022
  • 4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
  • 4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2028
  • 4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases
      • 5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions
      • 5.2.1.3 Development of wireless monitoring and wearable cardiac devices
      • 5.2.1.4 Increasing investments, funds, and grants for research on cardiac diagnosis
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets to offer high-growth opportunities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals
  • 5.3 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICE OF DIAGNOSTIC ECG MONITORING PRODUCTS (2022)
  • 5.4 PATENT ANALYSIS
    • FIGURE 19 PATENT ANALYSIS FOR DIAGNOSTIC ECG MARKET
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS OF DIAGNOSTIC ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 DIAGNOSTIC ECG MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REIMBURSEMENT SCENARIO
    • TABLE 4 CPT CODES FOR ECG PROCEDURES
  • 5.10 REGULATORY ANALYSIS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
      • 5.10.3.2 Japan
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
      • 5.10.4.1 Brazil
      • 5.10.4.2 Mexico
    • 5.10.5 MIDDLE EAST
    • 5.10.6 AFRICA
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 10 IMPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 11 EXPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY CONFERENCES & EVENTS, 2023-2024
    • TABLE 12 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR DIAGNOSTIC ECG MONITOR MANUFACTURERS
    • FIGURE 23 REVENUE SHIFT IN DIAGNOSTIC ECG MARKET
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS
    • 5.15.2 BUYING CRITERIA
    • FIGURE 25 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 14 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS

6 DIAGNOSTIC ECG MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 15 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 DEVICES
    • TABLE 16 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Wide availability of resting ECG devices to support market growth
    • TABLE 17 RESTING ECG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 High cost of stress ECG devices to limit adoption
    • TABLE 18 STRESS ECG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Growing demand for continuous monitoring to fuel growth
    • TABLE 19 HOLTER MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.4 EVENT MONITORS
      • 6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth
    • TABLE 20 EVENT MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.5 IMPLANTABLE LOOP RECORDERS
      • 6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth
    • TABLE 21 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.6 MOBILE CARDIAC TELEMETRY DEVICES
      • 6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market
    • TABLE 22 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.7 SMART ECG MONITORS
      • 6.2.7.1 Rising need to reduce treatment costs to drive adoption of smart/wearable ECG monitors
    • TABLE 23 SMART ECG MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 SOFTWARE & SERVICES
    • 6.3.1 SHIFT TOWARDS AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH
    • TABLE 24 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE

  • 7.1 INTRODUCTION
    • TABLE 25 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028(USD MILLION)
  • 7.2 12-LEAD ECG DEVICES
    • 7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH
    • TABLE 26 12-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.3 5-LEAD ECG DEVICES
    • 7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION
    • TABLE 27 5-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.4 3-LEAD ECG DEVICES
    • 7.4.1 ABILITY TO MEET NEEDS OF MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO SUPPORT MARKET
    • TABLE 28 3-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.5 6-LEAD ECG DEVICES
    • 7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH
    • TABLE 29 6-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.6 SINGLE-LEAD ECG DEVICES
    • 7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES
    • TABLE 30 SINGLE-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.7 OTHER ECG LEAD DEVICES
    • TABLE 31 OTHER ECG LEAD DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)

8 DIAGNOSTIC ECG MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 32 DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
    • 8.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS & CARDIAC CENTERS TO ACCELERATE MARKET GROWTH
    • TABLE 33 DIAGNOSTIC ECG MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 GROWING ADOPTION OF OUTPATIENT SURGERIES TO SUPPORT GROWTH
    • TABLE 34 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 35 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

9 DIAGNOSTIC ECG MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 36 DIAGNOSTIC ECG MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT
    • TABLE 37 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • 9.2.2 US
      • 9.2.2.1 Growing number of FDA approvals for ECG devices to support market growth
    • TABLE 41 US: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Growing focus of government and private organizations on providing funding for research to drive market growth
    • TABLE 42 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 43 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.1 EUROPE: RECESSION IMPACT
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany to dominate diagnostic ECG market in Europe during forecast period
    • TABLE 47 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising prevalence of heart failure to drive adoption of diagnostic ECG devices
    • TABLE 48 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Rising demand for home-based smart ECG devices to support market growth.
    • TABLE 49 UK: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Rising incidence of heart diseases to increase use of diagnostic ECG devices
    • TABLE 50 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising geriatric population to support market growth in Spain
    • TABLE 51 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 52 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT
    • TABLE 53 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 9.4.2 JAPAN
      • 9.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • TABLE 57 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Government support for infrastructural improvement to drive market growth
    • TABLE 58 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Government initiatives to propel market growth
    • TABLE 59 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing adoption of telemedicine and remote patient monitoring to boost market
    • TABLE 60 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising geriatric population to propel market growth
    • TABLE 61 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 62 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 63 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 65 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • 9.5.2 BRAZIL
      • 9.5.2.1 Improving access to diagnostic services to drive growth
    • TABLE 67 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Government support for infrastructural improvement to drive market growth
    • TABLE 68 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 69 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING MEDICAL COVERAGE IN REGION TO SUPPORT GROWTH
    • TABLE 70 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 28 KEY DEVELOPMENTS IN DIAGNOSTIC ECG MARKET (2020-2023)
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019-2022)
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 30 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
  • 10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
    • 10.5.1 STARS
    • 10.5.2 PERVASIVE PLAYERS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 31 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 32 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 OVERALL COMPANY FOOTPRINT
    • TABLE 73 OVERALL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
    • 10.7.2 COMPANY PRODUCT FOOTPRINT
    • TABLE 74 PRODUCT FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
    • 10.7.3 COMPANY REGIONAL FOOTPRINT
    • TABLE 75 REGIONAL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
  • 10.8 COMPETITIVE SCENARIO (2020-2023)
    • 10.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 76 DIAGNOSTIC ECG MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-AUGUST 2023)
    • 10.8.2 DEALS
    • TABLE 77 DIAGNOSTIC ECG MARKET: KEY DEALS (JANUARY 2020-AUGUST 2023)
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 78 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS (JANUARY 2020-AUGUST 2023)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 GE HEALTHCARE
    • TABLE 79 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 80 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.3 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.)
    • TABLE 81 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW
    • FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.4 FUKUDA DENSHI
    • TABLE 82 FUKUDA DENSHI: BUSINESS OVERVIEW
    • FIGURE 36 FUKUDA DENSHI: COMPANY SNAPSHOT (2022)
    • 11.1.5 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • TABLE 83 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • FIGURE 37 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021)
    • 11.1.6 NIHON KOHDEN CORPORATION
    • TABLE 84 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.7 OSI SYSTEMS, INC.
    • TABLE 85 OSI SYSTEMS, INC: BUSINESS OVERVIEW
    • FIGURE 39 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.8 BPL MEDICAL TECHNOLOGIES
    • TABLE 86 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
    • 11.1.9 SCHILLER AG
    • TABLE 87 SCHILLER AG: BUSINESS OVERVIEW
    • 11.1.10 BITTIUM
    • TABLE 88 BITTIUM: BUSINESS OVERVIEW
    • FIGURE 40 BITTIUM: COMPANY SNAPSHOT (2022)
    • 11.1.11 ACS DIAGNOSTICS
    • TABLE 89 ACS DIAGNOSTICS: BUSINESS OVERVIEW
    • 11.1.12 ALLENGERS MEDICAL SYSTEMS LTD.
    • TABLE 90 ALLENGERS MEDICAL SYSTEMS LTD: BUSINESS OVERVIEW
    • 11.1.13 BIONET
    • TABLE 91 BIONET: BUSINESS OVERVIEW
    • 11.1.14 CARDIAC INSIGHT, INC.
    • TABLE 92 CARDIAC INSIGHT, INC.: BUSINESS OVERVIEW
    • 11.1.15 BTL
    • TABLE 93 BTL: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 MEDITECH EQUIPMENT CO. LTD.
    • 11.2.2 MIDMARK CORPORATION
    • 11.2.3 ALIVECOR, INC.
    • 11.2.4 VITALCONNECT
    • 11.2.5 IRHYTHM TECHNOLOGIES, INC.
    • 11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
    • 11.2.7 NASIFF ASSOCIATES, INC.
    • 11.2.8 VECTRACOR
    • 11.2.9 BIOMEDICAL INSTRUMENTS CO. LTD.
    • 11.2.10 LIFESIGNALS, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS